The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases

The treatment of memory impairments associated with the central nervous system diseases remains an unmet medical need with social and economic implications. Here we show, that a multi-target ligand of aminergic G protein-coupled receptors with antipsychotic activity in vivo (D2AAK1) stimulates neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Koszła, Oliwia, Sołek, Przemysław, Woźniak, Sylwia, Kędzierska, Ewa, Wróbel, Tomasz M., Kondej, Magda, Archała, Aneta, Stępnicki, Piotr, Biała, Grażyna, Matosiuk, Dariusz, Kaczor, Agnieszka A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700684/
https://www.ncbi.nlm.nih.gov/pubmed/33238370
http://dx.doi.org/10.3390/ijms21228849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700684/
https://www.ncbi.nlm.nih.gov/pubmed/33238370
http://dx.doi.org/10.3390/ijms21228849

Ejemplares similares